Sponsor Content

Testosterone: A Patent-Pending Breakthrough Treatment for Crohn’s

October 1, 2020

2001

There doesn’t have to be a better way, because there already is.

Dr. Edward Lichten has made a career of not just treating the symptoms of disease, but addressing the causes and treating his patients so they can return to a normal, productive, and satisfying life.

First new patent-pending treatment for Crohn’s since Humira!

A leader in personalized treatment and immune-boosting science, Dr. Lichten has spent 50 years researching, studying, and creating a unique approach to strengthening an individual’s immune system. He’s considered one of the leading experts in the burgeoning field of hormonal immunology — the study of how sex hormones influence and control chronic autoimmune diseases such as Crohn’s disease, endometriosis, heart disease, and diabetes.

Dr. Lichten’s dedication to his work and his desire to find a better way has led to the first major breakthrough in two decades in the treatment of Crohn’s disease. His patent-pending program is the first new treatment for Crohn’s disease and ulcerative colitis since Humira™, and has proven to delay or even eliminate the need for surgery.

Testosterone: A possible alternative to surgery or expensive medication. A unique combination of FDA-approved medications with optimal results.

This isn’t guesswork, but science-driven treatment based on decades of research using FDA-approved medications that target the cause, not the symptoms.

“When your doctor can’t find a cause, they treat symptoms for a short period of time before surgery is necessary; meanwhile, the autoimmune disease continues to progress,” Dr. Lichten says. “What the internist should do is send the patient to us early, so we can add our medications and reduce the undeniable progression of the disease.”

Focus on the Cause: Treating symptoms doesn’t work. Inflammation is the “autoimmune” cause.

Dr. Lichten, who graduated from Ohio State University’s College of Medicine and Public Health in 1972 and founded the Lichten Wellness Center Testosterone: A Patent-Pending Breakthrough Treatment for Crohn’s in Birmingham in 1984, has seen patients go into remission of even the worst forms of Crohn’s disease and ulcerative colitis, also known as short bowel syndrome. “We believe we’re the first to have SBS patients return to full employment,” he says. “So far, up to two-thirds of biologic drug failures have become relatively symptom-free and may remain so for more than five years and without surgery.”